Compare Research Peptides
Select 2 peptides to compare benefits, dosage, administration routes, mechanisms, and side effect profiles side by side.
Select 2 peptides to compare benefits, dosage, administration routes, mechanisms, and side effect profiles side by side.
IGF-1 LR3 Long R3 IGF-1 | Follistatin FST | |
|---|---|---|
| Category | Muscle Growth & Performance | Muscle Growth & Performance |
| Key Benefits |
|
|
| Dosage | 20-100 mcg mcg | 100-300 mcg mcg |
| Frequency | Daily for maximum 4 weeks | Every other day or 2x weekly |
| Administration | SubcutaneousIntramuscular | Intramuscular |
| Mechanism | IGF-1 LR3 is a modified version of insulin-like growth factor-1 (IGF-1) with a longer half-life. The modifications make it more potent and prevent binding to IGF-binding proteins, allowing it to remain active in the body longer. It promotes muscle growth and fat loss. | Follistatin is a protein that inhibits myostatin, a negative regulator of muscle growth. By blocking myostatin, follistatin allows for increased muscle mass and strength. |
| Side Effects / Risks | Not specified | Not specified |
| Research Status | Research compound - not FDA approved | Research compound |
Long R3 IGF-1
Muscle Growth & PerformanceDosage
20-100 mcg mcg, Daily for maximum 4 weeks
Administration
Key Benefits
Research Status
Research compound - not FDA approved
FST
Muscle Growth & PerformanceDosage
100-300 mcg mcg, Every other day or 2x weekly
Administration
Key Benefits
Research Status
Research compound